학술논문
An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment
Document Type
Article
Source
In Clinical Therapeutics September 2020 42(9):1699-1714
Subject
Language
ISSN
0149-2918